Effectiveness of the golimumab educational program in ensuring healthcare professionals' awareness of risks described in the European risk management plan
Background: The golimumab safety awareness study commenced in 2010 to measure, periodically, the awareness of golimumab prescriber healthcare professionals (HCPs) of specific risks associated with golimumab as well as awareness of the requirement to provide a patient alert card to each patient treat...
Saved in:
Main Authors: | Lauren Felo (Author), Marijo Otero-Lobato (Author), Anja Geldhof (Author), Wim Noël (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Exposure to golimumab during pregnancy: Results from the Company's global safety database
by: Marijo Otero‐Lobato, et al.
Published: (2024) -
Risk Management Plans: reassessment of safety concerns based on Good Pharmacovigilance Practices Module V (Revision 2)-a company experience
by: Suzan Esslinger, et al.
Published: (2022) -
An appraisal of golimumab in the treatment of severe, active nonradiographic axial spondyloarthritis
by: Paccou J, et al.
Published: (2016) -
Golimumab in juvenile idiopathic arthritis-associated uveitis unresponsive to Adalimumab
by: Sofia Lanz, et al.
Published: (2021) -
Role of golimumab, a TNF-alpha inhibitor, in the treatment of the psoriatic arthritis
by: Melissa A Michelon, et al.
Published: (2010)